Correlation Between Cardio Diagnostics and Tempest Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cardio Diagnostics and Tempest Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cardio Diagnostics and Tempest Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cardio Diagnostics Holdings and Tempest Therapeutics, you can compare the effects of market volatilities on Cardio Diagnostics and Tempest Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cardio Diagnostics with a short position of Tempest Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cardio Diagnostics and Tempest Therapeutics.

Diversification Opportunities for Cardio Diagnostics and Tempest Therapeutics

-0.12
  Correlation Coefficient

Good diversification

The 3 months correlation between Cardio and Tempest is -0.12. Overlapping area represents the amount of risk that can be diversified away by holding Cardio Diagnostics Holdings and Tempest Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tempest Therapeutics and Cardio Diagnostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cardio Diagnostics Holdings are associated (or correlated) with Tempest Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tempest Therapeutics has no effect on the direction of Cardio Diagnostics i.e., Cardio Diagnostics and Tempest Therapeutics go up and down completely randomly.

Pair Corralation between Cardio Diagnostics and Tempest Therapeutics

Given the investment horizon of 90 days Cardio Diagnostics is expected to generate 3.34 times less return on investment than Tempest Therapeutics. But when comparing it to its historical volatility, Cardio Diagnostics Holdings is 3.14 times less risky than Tempest Therapeutics. It trades about 0.03 of its potential returns per unit of risk. Tempest Therapeutics is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  144.00  in Tempest Therapeutics on September 5, 2024 and sell it today you would lose (57.00) from holding Tempest Therapeutics or give up 39.58% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Cardio Diagnostics Holdings  vs.  Tempest Therapeutics

 Performance 
       Timeline  
Cardio Diagnostics 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Cardio Diagnostics Holdings are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very weak forward indicators, Cardio Diagnostics displayed solid returns over the last few months and may actually be approaching a breakup point.
Tempest Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Tempest Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Cardio Diagnostics and Tempest Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cardio Diagnostics and Tempest Therapeutics

The main advantage of trading using opposite Cardio Diagnostics and Tempest Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cardio Diagnostics position performs unexpectedly, Tempest Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tempest Therapeutics will offset losses from the drop in Tempest Therapeutics' long position.
The idea behind Cardio Diagnostics Holdings and Tempest Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Other Complementary Tools

Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins